Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AngloGold Ashanti PLCAU · Entity 3018 | Director | October 01, 2026 | October 02, 2026 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | Director | May 08, 2026 | May 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AngloGold Ashanti PLC
Report date October 01, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table I · non-derivative | Direct | 967 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 967 · Balance 967 F1: Each restricted share unit represents a contingent right to receive one Ordinary Share upon vesting, at which time all restrictions on the vested shares will lapse, subject to the continued service of the Reporting Person through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted share unit represents a contingent right to receive one Ordinary Share upon vesting, at which time all restrictions on the vested shares will lapse, subject to the continued service of the Reporting Person through the applicable vesting date.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date May 08, 2026 · Filed May 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,384 |
Reported balance
After 2026-05-08 transaction · row 1
1 source rowRow 1 · 2026-05-08 · Grant · Acquired 1,438 · Balance 2,384 F1: The unvested restricted stock units vest upon the earlier of 5/8/2027 or the business day prior to the Company's next annual meeting of shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The unvested restricted stock units vest upon the earlier of 5/8/2027 or the business day prior to the Company's next annual meeting of shareholders.
Past disclosures · reporting ended (4)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Arcadium Lithium plc
Report date March 06, 2025 · Filed March 06, 2025
Section 16 reporting ended · disclosed 2025-03-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2025-03-06 · Disposition to issuer · Disposed 332,275 · Balance 0 F1: Represents shares of common stock of Aracdium Lithium plc ("Arcadium") disposed of pursuant to the Transaction Agreement, dated October 9, 2024, by and among Arcadium, Rio Tinto Western Holdings Limited ("Parent") and Rio Tinto BM Subsidiary Limited ("Buyers") (the "Transaction Agreement"). Pursuant to the Transaction Agreement, at the effective time of the transaction contemplated thereby (the "Effective Time"), each share of Arcadium common stock held by the reporting person was converted automatically into the right to receive $5.85 per share in cash (the "Consideration"). |
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2025-03-06 · Disposition to issuer · Disposed 1,010,204 · Balance 0 F2: Pursuant to the Transaction Agreement, at the Effective Time, each Arcadium restricted stock units ("Arcadium RSU") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for restricted stock units with respect to a number of ordinary shares of either Rio Tinto plc or Rio Tinto Limited ("Listed Shares") of equivalent value and with the same terms and conditions as applied to such Arcadium RSU immediately prior to the Effective Time ("Rio Tinto RSUs"). The number of Listed Shares subject to such Rio Tinto RSUs equals one multiplied by an exchange ratio of 0.0920493627351811, which equals the quotient obtained by dividing (i) the Consideration by (ii) the average volume weighted average price per ordinary share of the applicable Listed Share for the 30 consecutive trading day period ending on the last trading day preceding the Effective Time (the "Equity Award Conversion Ratio"). |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Savings Plan | 0 |
Reported balance
After 2025-03-06 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2025-03-06 · Disposition to issuer · Disposed 235,345 · Balance 0 F1: Represents shares of common stock of Aracdium Lithium plc ("Arcadium") disposed of pursuant to the Transaction Agreement, dated October 9, 2024, by and among Arcadium, Rio Tinto Western Holdings Limited ("Parent") and Rio Tinto BM Subsidiary Limited ("Buyers") (the "Transaction Agreement"). Pursuant to the Transaction Agreement, at the effective time of the transaction contemplated thereby (the "Effective Time"), each share of Arcadium common stock held by the reporting person was converted automatically into the right to receive $5.85 per share in cash (the "Consideration"). |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.95 · Expires 2034-03-06 | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-03-06 · Disposition to issuer · Disposed 1,013,599 · Balance 0 F3: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium stock options ("Arcadium Options") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for an award of stock options with respect to a number of Listed Shares of equivalent value and with the same terms and conditions as applied to such stock options immediately prior to the Effective Time ("Rio Tinto Options"). The number of Listed Shares subject to each such Rio Tinto Options equals the number of shares of Arcadium common stock subject to the corresponding Arcadium Options immediately prior to the Effective Time multiplied by the Equity Award Conversion Ratio. The exercise price of each such Rio Tinto Option equals the exercise price of the corresponding Arcadium Options divided by the Equity Award Conversion Ratio. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.45 · Expires 2027-02-27 | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-03-06 · Disposition to issuer · Disposed 311,098 · Balance 0 F3: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium stock options ("Arcadium Options") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for an award of stock options with respect to a number of Listed Shares of equivalent value and with the same terms and conditions as applied to such stock options immediately prior to the Effective Time ("Rio Tinto Options"). The number of Listed Shares subject to each such Rio Tinto Options equals the number of shares of Arcadium common stock subject to the corresponding Arcadium Options immediately prior to the Effective Time multiplied by the Equity Award Conversion Ratio. The exercise price of each such Rio Tinto Option equals the exercise price of the corresponding Arcadium Options divided by the Equity Award Conversion Ratio. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.10 · Expires 2028-02-15 | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-03-06 · Disposition to issuer · Disposed 200,520 · Balance 0 F3: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium stock options ("Arcadium Options") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for an award of stock options with respect to a number of Listed Shares of equivalent value and with the same terms and conditions as applied to such stock options immediately prior to the Effective Time ("Rio Tinto Options"). The number of Listed Shares subject to each such Rio Tinto Options equals the number of shares of Arcadium common stock subject to the corresponding Arcadium Options immediately prior to the Effective Time multiplied by the Equity Award Conversion Ratio. The exercise price of each such Rio Tinto Option equals the exercise price of the corresponding Arcadium Options divided by the Equity Award Conversion Ratio. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.07 · Expires 2028-10-10 | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2025-03-06 · Disposition to issuer · Disposed 320,801 · Balance 0 F3: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium stock options ("Arcadium Options") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for an award of stock options with respect to a number of Listed Shares of equivalent value and with the same terms and conditions as applied to such stock options immediately prior to the Effective Time ("Rio Tinto Options"). The number of Listed Shares subject to each such Rio Tinto Options equals the number of shares of Arcadium common stock subject to the corresponding Arcadium Options immediately prior to the Effective Time multiplied by the Equity Award Conversion Ratio. The exercise price of each such Rio Tinto Option equals the exercise price of the corresponding Arcadium Options divided by the Equity Award Conversion Ratio. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.07 · Expires 2028-10-10 | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2025-03-06 · Disposition to issuer · Disposed 320,799 · Balance 0 F3: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium stock options ("Arcadium Options") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for an award of stock options with respect to a number of Listed Shares of equivalent value and with the same terms and conditions as applied to such stock options immediately prior to the Effective Time ("Rio Tinto Options"). The number of Listed Shares subject to each such Rio Tinto Options equals the number of shares of Arcadium common stock subject to the corresponding Arcadium Options immediately prior to the Effective Time multiplied by the Equity Award Conversion Ratio. The exercise price of each such Rio Tinto Option equals the exercise price of the corresponding Arcadium Options divided by the Equity Award Conversion Ratio. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.70 · Expires 2033-02-22 | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2025-03-06 · Disposition to issuer · Disposed 143,525 · Balance 0 F3: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium stock options ("Arcadium Options") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for an award of stock options with respect to a number of Listed Shares of equivalent value and with the same terms and conditions as applied to such stock options immediately prior to the Effective Time ("Rio Tinto Options"). The number of Listed Shares subject to each such Rio Tinto Options equals the number of shares of Arcadium common stock subject to the corresponding Arcadium Options immediately prior to the Effective Time multiplied by the Equity Award Conversion Ratio. The exercise price of each such Rio Tinto Option equals the exercise price of the corresponding Arcadium Options divided by the Equity Award Conversion Ratio. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.74 · Expires 2032-02-23 | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2025-03-06 · Disposition to issuer · Disposed 145,870 · Balance 0 F3: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium stock options ("Arcadium Options") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for an award of stock options with respect to a number of Listed Shares of equivalent value and with the same terms and conditions as applied to such stock options immediately prior to the Effective Time ("Rio Tinto Options"). The number of Listed Shares subject to each such Rio Tinto Options equals the number of shares of Arcadium common stock subject to the corresponding Arcadium Options immediately prior to the Effective Time multiplied by the Equity Award Conversion Ratio. The exercise price of each such Rio Tinto Option equals the exercise price of the corresponding Arcadium Options divided by the Equity Award Conversion Ratio. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.46 · Expires 2031-02-22 | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2025-03-06 · Disposition to issuer · Disposed 482,431 · Balance 0 F3: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium stock options ("Arcadium Options") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for an award of stock options with respect to a number of Listed Shares of equivalent value and with the same terms and conditions as applied to such stock options immediately prior to the Effective Time ("Rio Tinto Options"). The number of Listed Shares subject to each such Rio Tinto Options equals the number of shares of Arcadium common stock subject to the corresponding Arcadium Options immediately prior to the Effective Time multiplied by the Equity Award Conversion Ratio. The exercise price of each such Rio Tinto Option equals the exercise price of the corresponding Arcadium Options divided by the Equity Award Conversion Ratio. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock of Aracdium Lithium plc ("Arcadium") disposed of pursuant to the Transaction Agreement, dated October 9, 2024, by and among Arcadium, Rio Tinto Western Holdings Limited ("Parent") and Rio Tinto BM Subsidiary Limited ("Buyers") (the "Transaction Agreement"). Pursuant to the Transaction Agreement, at the effective time of the transaction contemplated thereby (the "Effective Time"), each share of Arcadium common stock held by the reporting person was converted automatically into the right to receive $5.85 per share in cash (the "Consideration").
F2: Pursuant to the Transaction Agreement, at the Effective Time, each Arcadium restricted stock units ("Arcadium RSU") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for restricted stock units with respect to a number of ordinary shares of either Rio Tinto plc or Rio Tinto Limited ("Listed Shares") of equivalent value and with the same terms and conditions as applied to such Arcadium RSU immediately prior to the Effective Time ("Rio Tinto RSUs"). The number of Listed Shares subject to such Rio Tinto RSUs equals one multiplied by an exchange ratio of 0.0920493627351811, which equals the quotient obtained by dividing (i) the Consideration by (ii) the average volume weighted average price per ordinary share of the applicable Listed Share for the 30 consecutive trading day period ending on the last trading day preceding the Effective Time (the "Equity Award Conversion Ratio").
F3: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium stock options ("Arcadium Options") held by the reporting person and granted under the Arcadium Omnibus Incentive Plan was canceled in exchange for an award of stock options with respect to a number of Listed Shares of equivalent value and with the same terms and conditions as applied to such stock options immediately prior to the Effective Time ("Rio Tinto Options"). The number of Listed Shares subject to each such Rio Tinto Options equals the number of shares of Arcadium common stock subject to the corresponding Arcadium Options immediately prior to the Effective Time multiplied by the Equity Award Conversion Ratio. The exercise price of each such Rio Tinto Option equals the exercise price of the corresponding Arcadium Options divided by the Equity Award Conversion Ratio.
FMC CORP
Report date March 01, 2019 · Filed March 05, 2019
Section 16 reporting ended · disclosed 2019-03-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 68,087 |
Reported balance
After 2019-03-01 transaction · row 1
1 source rowRow 1 · 2019-03-01 · Disposition to issuer · Disposed 14,118 · Balance 68,087 F1: Represents the conversion of restricted stock units ("FMC RSUs") with respect to shares of common stock of FMC Corporation ("FMC"), par value $0.10 per share ("FMC Common Stock"), held by the Reporting Person as of March 1, 2019, into restricted stock units with respect to shares of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent ("EMA") and the anti-dilution adjustment provisions under the FMC Incentive Compensation and Stock Plan ("FMC Plan"), in connection with the prorata spinoff distribution ("Distribution") by FMC of all of its shares of Livent Common Stock to the holders of record of FMC Common Stock on February 25, 2019. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $59.47 · Expires 2023-02-18 | Direct | 0 |
Reported balance
After 2019-03-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-03-01 · Disposition to issuer · Disposed 12,246 · Balance 0 F2: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $72.93 · Expires 2024-02-17 | Direct | 0 |
Reported balance
After 2019-03-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-03-01 · Disposition to issuer · Disposed 10,252 · Balance 0 F2: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $63.41 · Expires 2025-02-27 | Direct | 0 |
Reported balance
After 2019-03-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-03-01 · Disposition to issuer · Disposed 13,986 · Balance 0 F2: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $57.63 · Expires 2027-02-27 | Direct | 0 |
Reported balance
After 2019-03-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-03-01 · Disposition to issuer · Disposed 18,591 · Balance 0 F2: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $85.24 · Expires 2028-02-15 | Direct | 0 |
Reported balance
After 2019-03-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-03-01 · Disposition to issuer · Disposed 11,983 · Balance 0 F2: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the conversion of restricted stock units ("FMC RSUs") with respect to shares of common stock of FMC Corporation ("FMC"), par value $0.10 per share ("FMC Common Stock"), held by the Reporting Person as of March 1, 2019, into restricted stock units with respect to shares of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between FMC and Livent ("EMA") and the anti-dilution adjustment provisions under the FMC Incentive Compensation and Stock Plan ("FMC Plan"), in connection with the prorata spinoff distribution ("Distribution") by FMC of all of its shares of Livent Common Stock to the holders of record of FMC Common Stock on February 25, 2019.
F2: Represents the conversion of stock options to purchase FMC Common Stock ("FMC Options") into stock options to purchase Livent Common Stock ("Livent Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution.
LYDALL INC /DE/
Report date October 01, 2021 · Filed October 05, 2021
Section 16 reporting ended · disclosed 2021-10-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-10-01 transaction · row 1
1 source rowRow 1 · 2021-10-01 · Disposition to issuer · Disposed 773 · Balance 0 F1: Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of June 21, 2021, by and among Lydall, Inc., Unifrax Holding Co., Outback Merger Sub, Inc. and Unifrax I LLC, as it may be amended from time to time, referred to as the Merger Agreement. F2: Each share of common stock was cancelled pursuant to the Merger Agreement in exchange for the right to receive $62.10 in cash per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of June 21, 2021, by and among Lydall, Inc., Unifrax Holding Co., Outback Merger Sub, Inc. and Unifrax I LLC, as it may be amended from time to time, referred to as the Merger Agreement.
F2: Each share of common stock was cancelled pursuant to the Merger Agreement in exchange for the right to receive $62.10 in cash per share.
Livent Corp.
Report date January 04, 2024 · Filed January 08, 2024
Section 16 reporting ended · disclosed 2024-01-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-01-04 transaction · row 1
1 source rowRow 1 · 2024-01-04 · Disposition to issuer · Disposed 355,541 · Balance 0 F1: Represents the conversion of common stock and restricted stock units ("Livent RSUs") with respect to shares of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into ordinary shares and restricted stock units with respect to ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 per share ("Arcadium Ordinary Shares"), in accordance with the terms of the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction. |
| Common StockSEC Table I · non-derivative | Indirectby Savings Plan | 0 |
Reported balance
After 2024-01-04 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2024-01-04 · Disposition to issuer · Disposed 97,815 · Balance 0 F2: Represents the conversion of common stock held by the Livent Nonqualified Savings Plan (the "Livent NQ Savings Plan") into Arcadium Ordinary Shares held by such Livent NQ Savings Plan, upon the assumption by Arcadium of the obligations of Livent under the Livent NQ Savings Plan in connection with the merger of equals transaction. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.33 · Expires 2033-02-22 | Direct | 0 |
Reported balance
After 2024-01-04 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-01-04 · Disposition to issuer · Disposed 59,653 · Balance 0 F3: Represents the conversion of stock options to purchase Livent Common Stock ("Livent Options") into stock options to purchase Arcadium Ordinary Shares ("Arcadium Options"), in accordance with the terms of the Transaction Agreement, in connection with the merger of equals transaction. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.01 · Expires 2032-02-23 | Direct | 0 |
Reported balance
After 2024-01-04 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-01-04 · Disposition to issuer · Disposed 60,628 · Balance 0 F3: Represents the conversion of stock options to purchase Livent Common Stock ("Livent Options") into stock options to purchase Arcadium Ordinary Shares ("Arcadium Options"), in accordance with the terms of the Transaction Agreement, in connection with the merger of equals transaction. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.35 · Expires 2031-02-22 | Direct | 0 |
Reported balance
After 2024-01-04 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-01-04 · Disposition to issuer · Disposed 200,512 · Balance 0 F3: Represents the conversion of stock options to purchase Livent Common Stock ("Livent Options") into stock options to purchase Arcadium Ordinary Shares ("Arcadium Options"), in accordance with the terms of the Transaction Agreement, in connection with the merger of equals transaction. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the conversion of common stock and restricted stock units ("Livent RSUs") with respect to shares of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into ordinary shares and restricted stock units with respect to ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 per share ("Arcadium Ordinary Shares"), in accordance with the terms of the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction.
F2: Represents the conversion of common stock held by the Livent Nonqualified Savings Plan (the "Livent NQ Savings Plan") into Arcadium Ordinary Shares held by such Livent NQ Savings Plan, upon the assumption by Arcadium of the obligations of Livent under the Livent NQ Savings Plan in connection with the merger of equals transaction.
F3: Represents the conversion of stock options to purchase Livent Common Stock ("Livent Options") into stock options to purchase Arcadium Ordinary Shares ("Arcadium Options"), in accordance with the terms of the Transaction Agreement, in connection with the merger of equals transaction.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2018 Filed Feb 20, 2018 20:43 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 4,998 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-007122 · form4.xml · nonDerivative · entry 2 Graves Paul W · CIK 0001559551 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,000 Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 20:43 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 3,561 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-007122 · form4.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,002 Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:23 UTC | FMC CORP FMC · Entity 4704 | GrantStock Option (Right to Buy) · Derivative | 18,591 | $0.00 Strike: $57.63 | $0.00 |
DisclosureSEC source: 0001127602-17-009269 · form4.xml · derivative · entry 6 Graves Paul W · CIK 0001559551 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,591 Underlying: Common Stock · 18,591 shares Expires 2027-02-27 Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:23 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 59 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009269 · form4.xml · nonDerivative · entry 4 Graves Paul W · CIK 0001559551 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,441 F1 · shares: These shares were issued pursuant to dividend equivalent rights accrued with respect to performance based restricted stock units that were "banked" as of this date. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:23 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 4,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009269 · form4.xml · nonDerivative · entry 3 Graves Paul W · CIK 0001559551 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,382 Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:23 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 5,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009269 · form4.xml · nonDerivative · entry 2 Graves Paul W · CIK 0001559551 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,394 Read SEC document |
| February 17, 2017 Filed Mar 1, 2017 21:23 UTC | FMC CORP FMC · Entity 4704 | Tax withholdingCommon Stock | 1,656 | $57.83 | $95,766.48 |
DisclosureSEC source: 0001127602-17-009269 · form4.xml · nonDerivative · entry 1 Graves Paul W · CIK 0001559551 · Exec VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,347 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.